Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 3284 entries
View as:

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT06602479 Org: User:
Start: 10/07/24 End: 09/15/25 Due: 09/15/26

Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT06231693 Org: User:
Start: 12/04/23 End: 03/26/24 Due: 03/26/25

A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Phase: N/A Priority: Normal
NCT ID: NCT01880424 Org: User:
Start: 07/31/13 End: 05/31/15 Due: 05/31/16

Aclidinium/Formoterol Fixed Combination Dose Finding Study

Phase: N/A Priority: Normal
NCT ID: NCT00626522 Org: User:
Start: 02/29/08 End: 11/30/08 Due: 11/30/09

Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration.

Phase: N/A Priority: Normal
NCT ID: NCT01887626 Org: User:
Start: 07/31/13 End: 09/30/13 Due: 09/30/14

Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)

Phase: N/A Priority: Normal
NCT ID: NCT05771480 Org: User:
Start: 08/16/23 End: 03/17/26 Due: 03/17/27

Food Effect Study of a Single Dose of ZD4054 (Zibotentan)

Phase: N/A Priority: Normal
NCT ID: NCT00710047 Org: User:
Start: 06/30/08 End: 08/31/08 Due: 08/31/09

A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02479412 Org: User:
Start: 06/25/15 End: 02/08/16 Due: 02/08/17

A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00234429 Org: User:
Start: 11/30/03 End: 06/30/06 Due: 06/30/07

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS)

Phase: N/A Priority: Normal
NCT ID: NCT01329029 Org: User:
Start: 05/31/11 End: 05/31/14 Due: 05/31/15

A Global Study to Assess the Effects of MEDI4736 (Durvalumab), Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02352948 Org: User:
Start: 01/13/15 End: 08/30/23 Due: 08/30/24

Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01931761 Org: User:
Start: 10/31/13 End: 11/30/13 Due: 11/30/14

A Study of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01392820 Org: User:
Start: 07/31/11 End: 10/31/11 Due: 10/31/12

Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00097500 Org: User:
Start: 09/30/04 End: 12/31/09 Due: 12/31/10

Open Label, Healthy Volunteers, ADME Study With Single Oral Administration of [14C] AZD5069

Phase: N/A Priority: Normal
NCT ID: NCT01332903 Org: User:
Start: 05/31/11 End: 07/31/11 Due: 07/31/12

Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)

Phase: N/A Priority: Normal
NCT ID: NCT06472310 Org: User:
Start: 06/06/24 End: 06/30/27 Due: 06/30/28

A Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (IVOLGA)

Phase: N/A Priority: Normal
NCT ID: NCT06943833 Org: User:
Start: 03/31/25 End: 03/30/29 Due: 03/30/30

IMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03643484 Org: User:
Start: 10/24/18 End: 06/30/21 Due: 06/30/22

Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and Prasugrel

Phase: N/A Priority: Normal
NCT ID: NCT01276275 Org: User:
Start: 01/31/14 End: 04/30/15 Due: 04/30/16

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4041 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04076540 Org: User:
Start: 10/03/19 End: 01/02/22 Due: 01/02/23

A Study of Acalabrutinib Suspension to Evaluate Relative Bioavailability and Proton-pump Inhibitor Effect in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04435483 Org: User:
Start: 05/22/20 End: 06/26/20 Due: 06/26/21

A Healthy Female and Male Volunteers Aspirin Study

Phase: N/A Priority: Normal
NCT ID: NCT01448031 Org: User:
Start: 11/30/11 End: 04/30/12 Due: 04/30/13

Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Treatment With Dapagliflozin Versus Sitagliptin: An Analysis of Commercial Claims and Linked Laboratory Data

Phase: N/A Priority: Normal
NCT ID: NCT03078049 Org: User:
Start: 03/31/17 End: 05/31/17 Due: 05/31/18

Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02197247 Org: User:
Start: 12/04/14 End: 05/26/21 Due: 05/26/22

ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study

Phase: N/A Priority: Normal
NCT ID: NCT00745875 Org: User:
Start: 08/31/08 End: 01/31/10 Due: 01/31/11